These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11363352)

  • 21. Combination therapy with ZDV + DDI versus ZDV + DDC in patients with progression of HIV-infection under treatment with ZDV.
    Mauss S; Adams O; Willers R; Jablonowski H
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(5):469-77. PubMed ID: 8605592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytomegalovirus retinitis under combination therapy with zidovudine and dideoxycytidine in advanced human immunodeficiency virus infection.
    Kaulen P; Pham DT; Baranowski E; Wollensak J
    Ger J Ophthalmol; 1993 Nov; 2(6):412-5. PubMed ID: 8312826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group.
    Katlama C; Ingrand D; Loveday C; Clumeck N; Mallolas J; Staszewski S; Johnson M; Hill AM; Pearce G; McDade H
    JAMA; 1996 Jul; 276(2):118-25. PubMed ID: 8656503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of antiretroviral drug therapy in human immunodeficiency virus infection.
    Stretcher B
    Crit Rev Clin Lab Sci; 1994; 31(2):169-96. PubMed ID: 7917008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New developments in antiretroviral drug therapy for HIV-1 infections.
    Johnson VA
    AIDS Clin Rev; 1995-1996; ():305-46. PubMed ID: 7488558
    [No Abstract]   [Full Text] [Related]  

  • 26. Response of CD4 lymphocytes and clinical consequences of treatment using ddI or ddC in patients with advanced HIV infection.
    Goldman AI; Carlin BP; Crane LR; Launer C; Korvick JA; Deyton L; Abrams DI
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Feb; 11(2):161-9. PubMed ID: 8556398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Confirmation for combination AIDS therapy.
    Science; 1995 Oct; 270(5233):33. PubMed ID: 7569948
    [No Abstract]   [Full Text] [Related]  

  • 28. Current use of anti-HIV drugs in AIDS.
    Clumeck N
    J Antimicrob Chemother; 1993 Jul; 32 Suppl A():133-8. PubMed ID: 8407695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors associated with changes in the use of antiretroviral therapy by a cohort of homosexual men infected with human immunodeficiency virus type 1.
    Park LP; Graham NM; Jacobson LP; Murphy R; Besley D; Zucconi S; Muñoz A
    Clin Infect Dis; 1995 Oct; 21(4):930-7. PubMed ID: 8645842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pilot study of sequential therapy with zidovudine plus acyclovir, dideoxyinosine, and dideoxycytidine in patients with severe human immunodeficiency virus infection.
    Nguyen BY; Shay LE; Wyvill KM; Pluda JM; Brawley O; Cohen RB; Whitcup SM; Venzon DJ; Broder S; Yarchoan R
    J Infect Dis; 1993 Oct; 168(4):810-7. PubMed ID: 8397267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of HIV infection: the antiretroviral nucleoside analogues. Nucleoside analogues: combination therapy.
    McLeod GX; Hammer SM
    Hosp Pract (Off Ed); 1992 Aug; 27 Suppl 2():14-25. PubMed ID: 1324254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiretroviral therapy for human immunodeficiency virus infection: hope and despair.
    Picard O
    Biomed Pharmacother; 1994; 48(2):85-8. PubMed ID: 7919110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New developments in antiretroviral drug therapy for HIV infection.
    Johnson VA
    AIDS Clin Rev; 1992; ():69-104. PubMed ID: 1318738
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical trials of combination therapies for HIV infection. Rationale for development of multidrug therapy.
    Hoth D
    J Acquir Immune Defic Syndr (1988); 1990; 3 Suppl 2():S95-6. PubMed ID: 2172506
    [No Abstract]   [Full Text] [Related]  

  • 35. AZT/ddC combination may benefit AIDS sufferers.
    Oncology (Williston Park); 1989 Jan; 3(1):107. PubMed ID: 2561878
    [No Abstract]   [Full Text] [Related]  

  • 36. Switching from zidovudine to didanosine in patients with symptomatic HIV infection and disease progression. ddI Iberian Study Group.
    Gatell JM; González-Lahoz J; Clotet B; Antunes F; Kasparova L; Gil-Aguado A; Saballs P; Santamaria JM; Podzamczer D; Miro JM; Jou A; Verdejo J; Doroana M; Thomis J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jul; 12(3):249-58. PubMed ID: 8673528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AIDS Clinical Trials Group: phase I/II study of combination 2',3'-dideoxycytidine and zidovudine in patients with acquired immunodeficiency syndrome (AIDS) and advanced AIDS-related complex.
    Meng TC; Fischl MA; Richman DD
    Am J Med; 1990 May; 88(5B):27S-30S. PubMed ID: 2159707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of HIV infection: the antiretroviral nucleoside analogues. Introduction.
    McLeod GX; Hammer SM
    Hosp Pract (Off Ed); 1992 Aug; 27 Suppl 2():3-4. PubMed ID: 1324256
    [No Abstract]   [Full Text] [Related]  

  • 39. Controversies in anti-retroviral therapy of adults.
    Khoo SH; Wilkins EG
    J Antimicrob Chemother; 1995 Feb; 35(2):245-62. PubMed ID: 7759389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination therapy with zidovudine, didanosine and saquinavir.
    Collier AC; Coombs RW; Schoenfeld DA; Bassett R; Baruch A; Corey L
    Antiviral Res; 1996 Jan; 29(1):99. PubMed ID: 8721557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.